tirzepatide 30 mg vial (30mg Vial) Dosage Protocol Tirzepatide 30mg Pen Refill Vial

Tirzepatide achieved 20.9% weight loss at 72 weeks in SURMOUNT-1 (15mg)

As of August 2023, 40.3% of US adults were classified as obese, and in 2021, about 38.4 million Americans, or 11.6% of the US population, were living with diabetes

(2024) CDC [accessed 30 January 2026]

Active-Comparator New-User Cohort Analysis The risk for NAION using the sensitive definition was not different among new semaglutide users compared with dulaglutide (meta-analysis HR, 0.93

At Clarity Medical Spa, we offer a variety of non-surgical services, including advanced skin tightening treatments, designed to deliver the dramatic, long-lasting results you desire

At least 25 companies are developing GLP-1 and related molecules, with several in late-stage trials showing weight loss exceeding current approved options